Vaccine passports ditched in UK’s new plan to manage Covid-19 pandemic

British Prime Minister Boris Johnson will set out on Tuesday his plans to manage the Covid-19 pandemic in the winter months, announcing a decision to scrap the introduction of vaccine passports and steps to end some emergency powers. Johnson, under fire from some in his governing Conservative Party for raising taxes to fix a health … Read more

Pharmaceutical firms turn focus to inhalation products for Covid-19

After injectables and oral solid drugs, now pharmaceutical firms are focusing on coming up with re-purposed inhalation products for Covid-19. While drug major Lupin is working on a remdesivir powder for inhalation, Mumbai-based Glenmark has tied up with a Canadian Biotech firm for Nitric Oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission. … Read more

Tech Mahindra expects to begin trials for planned COVID drug in 3-4 months

After receiving the patent for a particular molecule, according to a senior official. Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. “We … Read more

Covid death: Companies continue pay, support kids’ education

More companies have rolled out a Covid support policy for families of employees claimed by the infection. India’s largest metal producer Tata Steel announced that it will continue to pay salary to the deceased employee’s family till the retirement age of 60 years. The salary will be the same as his last compensation which he … Read more

Deloitte has designed programme that can be scaled in Covid fight, says CEO

Deloitte, one of the Big Four accounting organisations, has developed “a very innovative, simple, fit-for-purpose programme” in the fight against COVID-19 that can be scaled up in a quick span of time, its CEO Punit Renjen said on Monday. “We have designed, I believe, a very innovative, simple, fit-for-purpose programme that is integrated,” Renjen told … Read more

The 44-year-old successor to billionaire ‘Bond King’ Bill Gross is retiring early to go on road trips with his kids. ‘The pandemic has caused everybody to reevaluate.’

Nick Maroutsos, head of global bonds at Janus Henderson Investors, told Bloomberg he will retire in October. The 44-year-old said the pandemic had made him reevaluate his life. He wanted to spend time with his kids, he said. Maroutsos took over from legendary billionaire “Bond King” Bill Gross in 2019. See more stories on Insider’s … Read more